Chen, S., Okahara, F., Osaki, N
Its two RLT products Lutathera (lutetium-177 DOTATATE) for gastroenteropancreatic neuroendocrine tumours (GEP-NETs) and Pluvicto (lutetium-177 PSMA-617) for metastatic castration-resistant prostate cancer represent the most commercially advanced radioligand therapy platform in the world and occupy the Oncology Peptide Therapy segment, which the report forecasts to grow at 11.79% CAGR through 2031
According to an investigation, treatment with LC (500 mg/kg) on carbendazim-challenged rats resulted in overexpression of Star mRNA, which was in line with our study because carbendazim also generates reproductive toxicity in the male rats [55]
DNA fragmentation occurs in skeletal muscle during tumor growth: A link with cancer cachexia
The OM functions as a semipermeable barrier that facilitates the uptake of essential nutrients while restricting the entry of harmful substances, including antibiotics [22]